Preventive PCI versus only optimal medical therapy for vulnerable plaques
Marc Bonaca, MD
Self-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes, MD, PhD
Stopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Michael Koren, MD
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.